{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T14:13:14Z","timestamp":1781100794992,"version":"3.54.1"},"reference-count":404,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1016\/s0165-4608(03)00105-5","type":"journal-article","created":{"date-parts":[[2003,7,31]],"date-time":"2003-07-31T22:43:15Z","timestamp":1059691395000},"page":"1-30","source":"Crossref","is-referenced-by-count":196,"title":["Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors"],"prefix":"10.1016","volume":"145","author":[{"given":"Avery A","family":"Sandberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia A","family":"Bridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S0165-4608(03)00105-5_BIB1","series-title":"The cytogenetics of bone and soft tissue tumors","author":"Sandberg","year":"1994"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB2","series-title":"Molecular biology and pathology of paediatric cancer","article-title":"Osteosarcoma","author":"Bell","year":"2002"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB3","series-title":"Bone tumors","author":"Dorfman","year":"1998"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB4","series-title":"Bone and soft tissue tumors","author":"Campanacci","year":"1999"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00003086-197509000-00004","article-title":"Pathology of osteosarcoma","volume":"111","author":"Dahlin","year":"1975","journal-title":"Clin Orthop"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1200\/JCO.1992.10.1.5","article-title":"Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience","volume":"10","author":"Meyers","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1200\/JCO.1993.11.3.449","article-title":"Osteogenic sarcoma with clinically detectable metastasis at initial presentation","volume":"11","author":"Meyers","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB8","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0031-3955(05)70540-X","article-title":"Osteosarcoma","volume":"44","author":"Meyers","year":"1997","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB9","series-title":"Enzinger and Weiss' soft tissue tumors","author":"Weiss","year":"2001"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB10","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1002\/1097-0142(19940515)73:10<2653::AID-CNCR2820731030>3.0.CO;2-G","article-title":"Postirradiation sarcomas: a single-institution study and review of the literature","volume":"73","author":"Mark","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB11","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/modpathol.3880420","article-title":"Orthopaedic implant-related sarcoma: a study of twelve cases","volume":"14","author":"Keel","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB12","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/bjc.1986.110","article-title":"Second primary neoplasms in patients with retinoblastoma","volume":"53","author":"Draper","year":"1986","journal-title":"Br J Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1056\/NEJM199907293410507","article-title":"Common musculoskeletal tumors of childhood and adolescence","volume":"341","author":"Arndt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00000478-197701010-00007","article-title":"Osteosarcomas of bone and its important recognizable varieties","volume":"1","author":"Dahlin","year":"1977","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB15","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1200\/JCO.1996.14.3.848","article-title":"Tumor size and prognosis in aggressively treated osteosarcoma","volume":"14","author":"Bieling","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1081\/CNV-100102557","article-title":"Current treatment of osteosarcoma","volume":"19","author":"Ferguson","year":"2001","journal-title":"Cancer Invest"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB17","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/cncr.10944","article-title":"Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?","volume":"95","author":"Jaffe","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB18","first-page":"327","article-title":"Osteosarcoma: clinical and pathological considerations","volume":"20","author":"Klein","year":"1989","journal-title":"Orthop Clin North Am"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB19","first-page":"1023","article-title":"Current aspects of the pathology of osteosarcoma","volume":"15","author":"Grundmann","year":"1995","journal-title":"Anticancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB20","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0344-0338(11)80877-0","article-title":"New aspects of cell biology in osteosarcoma","volume":"191","author":"Grundmann","year":"1995","journal-title":"Pathol Res Pract"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB21","series-title":"Bone tumors: general aspects and data on 8,542 cases","author":"Dahlin","year":"1986"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB22","series-title":"Principles and practice of pediatric oncology","first-page":"889","article-title":"Osteosarcoma","author":"Link","year":"1997"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB23","series-title":"Osteosarcoma in adolescents and young adults","first-page":"163","article-title":"Osteosarcomatosis and metastatic osteosarcoma","author":"Hopper","year":"1993"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB24","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/1097-0142(19870901)60:5<1132::AID-CNCR2820600536>3.0.CO;2-L","article-title":"Extraskeletal osteosarcoma","volume":"60","author":"Chung","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB25","series-title":"Pathology and genetics of tumours of soft tissue and bone. World Health Organization Classification of Tumours","year":"2002"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00003086-199109000-00031","article-title":"Molecular genetic considerations in osteosarcoma","volume":"270","author":"Hansen","year":"1991","journal-title":"Clin Orthop"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/15227950050193641","article-title":"Molecular pathology and molecular pharmacology of osteosarcoma","volume":"19","author":"Ladanyi","year":"2000","journal-title":"Pediatr Pathol Mol Med"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB28","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1053\/hp.2000.6706","article-title":"Contribution of molecular genetic data to the classification of sarcomas","volume":"31","author":"Ladanyi","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB29","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0959-8049(97)00062-2","article-title":"A survey of telomerase activity in human cancer","volume":"33","author":"Shay","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB30","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/nm1197-1271","article-title":"Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines","volume":"3","author":"Bryan","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB31","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1200\/JCO.2000.18.13.2626","article-title":"Role of telomerase in normal and cancer cells","volume":"18","author":"Meyerson","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB32","first-page":"2953","article-title":"Telomerase and cancer: where and when?","volume":"7","author":"Hahn","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB33","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1056\/NEJM200004273421710","article-title":"Telomeres, telomerase, and cancer","volume":"342","author":"Buys","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB34","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1038\/sj.onc.1204493","article-title":"Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas","volume":"20","author":"Scheel","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB35","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/sj.onc.1205058","article-title":"Alternative lengthening of telomeres in mammalian cells","volume":"21","author":"Henson","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB36","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/hmg\/10.18.1953","article-title":"Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway","volume":"10","author":"Grobelny","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"suppl 1","key":"10.1016\/S0165-4608(03)00105-5_BIB37","first-page":"S68","article-title":"Telomerase activity in human solid tumors: diagnostic utility and clinical applications","volume":"112","author":"Vasef","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB38","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/323643a0","article-title":"A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma","volume":"323","author":"Friend","year":"1986","journal-title":"Nature"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB39","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1073\/pnas.82.18.6216","article-title":"Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition","volume":"82","author":"Hansen","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB40","first-page":"59","article-title":"Chromosome 13 homozygosity in osteosarcoma without retinoblastoma","volume":"38","author":"Dryja","year":"1986","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB41","first-page":"235","article-title":"Alterations of retinoblastoma susceptibility gene accompanied by c-MYC amplification in human bone and soft tissue tumors","volume":"39","author":"Ozaki","year":"1993","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB42","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0046-8177(97)90107-6","article-title":"Malignancy after retinoblastoma: secondary cancer or recurrence?","volume":"28","author":"Dickman","year":"1997","journal-title":"Hum Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB43","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1001\/jama.1997.03550150066037","article-title":"Cancer incidence after retinoblastoma: radiation dose and sarcoma risk","volume":"278","author":"Wong","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1076\/opge.22.2.77.2228","article-title":"Osteosarcoma following retinoblastoma: age at onset and latency period","volume":"22","author":"Chauveinc","year":"2001","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB45","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jmg.11.3.244","article-title":"Pleiotropic effects of the gene for retinoblastoma","volume":"11","author":"Kitchin","year":"1974","journal-title":"J Med Genet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB46","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0161-6420(84)34127-6","article-title":"Second nonocular tumors in retinoblastoma survivors: are they radiation-induced?","volume":"91","author":"Abramson","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB47","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00003086-199109000-00035","article-title":"Involvement of the retinoblastoma gene in primary osteosarcomas and other bone and soft-tissue tumors","volume":"270","author":"Araki","year":"1991","journal-title":"Clin Orthop"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB48","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/jnci\/83.3.194","article-title":"Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas","volume":"83","author":"Wunder","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB49","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/08880019209018328","article-title":"Studies of the RB1 gene and the p53 gene in human osteosarcomas","volume":"9","author":"Scholz","year":"1992","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB50","first-page":"3042","article-title":"Mutation spectrum of the retinoblastoma gene in osteosarcoma","volume":"54","author":"Wadayama","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB51","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00019606-199609000-00011","article-title":"Loss of heterozygosity and microsatellite instability at the retinoblastoma locus in osteosarcomas","volume":"5","author":"Belchis","year":"1996","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB52","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/15227950050193632","article-title":"Alterations in the RB, p16, and cyclin D1 cell cycle control pathway in osteosarcomas","volume":"19","author":"Belchis","year":"2000","journal-title":"Pediatr Pathol Mol Med"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB53","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/BF01213553","article-title":"Alterations of the p53, Rb and MDM2 genes in osteosarcoma","volume":"122","author":"Miller","year":"1996","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB54","first-page":"3939","article-title":"Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcomas","volume":"48","author":"Toguchida","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB55","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/(SICI)1097-0215(19991022)84:5<489::AID-IJC7>3.0.CO;2-D","article-title":"Alteration of pRB\/p16\/cdk4 regulation in human osteosarcoma","volume":"84","author":"Benassi","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00019606-200103000-00003","article-title":"A microsatellite fluorescent method for linkage analysis in familial retinoblastoma and deletion detection at the RB1 locus in retinoblastoma and osteosarcoma","volume":"10","author":"Alonso","year":"2001","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB57","first-page":"2419","article-title":"Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q","volume":"52","author":"Yamaguchi","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB58","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1200\/JCO.1996.14.2.467","article-title":"Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma","volume":"14","author":"Feugeas","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB59","first-page":"6393","article-title":"Weichselbaum RR. p53 mutations and abnormal retinoblastoma protein in radiation-induced human sarcomas","volume":"51","author":"Brachman","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB60","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/(SICI)1097-4652(199711)173:2<233::AID-JCP27>3.0.CO;2-F","article-title":"Role of the RB\/E2F pathway in cell growth control","volume":"173","author":"Nevins","year":"1997","journal-title":"J Cell Physiol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB61","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/(SICI)1097-0215(19971021)74:5<518::AID-IJC7>3.0.CO;2-6","article-title":"Altered G1 phase regulation in osteosarcoma","volume":"74","author":"Benassi","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB62","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/15227950050193623","article-title":"Cytogenetic findings in 36 osteosarcoma specimens and a review of the literature","volume":"19","author":"Boehm","year":"2000","journal-title":"Pediatr Pathol Mol Med"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB63","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0065-230X(08)60352-8","article-title":"Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer","volume":"68","author":"Hall","year":"1996","journal-title":"Adv Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB64","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0002-9440(10)65556-3","article-title":"CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations","volume":"153","author":"Nielsen","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB65","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00019606-199712000-00005","article-title":"Molecular alterations of the RB1, TP53, and MDM2 genes in primary and xenografted human osteosarcomas","volume":"6","author":"Pell\u0131\u0301n","year":"1997","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB66","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1038\/sj.onc.1202777","article-title":"Bartek J. p16INK4a, but not constitutively active pRb, can impose a sustained G1 arrest: molecular mechanisms and implications for oncogenesis","volume":"18","author":"Lukas","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB67","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/(SICI)1097-0215(19990118)80:2<199::AID-IJC7>3.0.CO;2-4","article-title":"CDK4 gene amplification in osteosarcoma: reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons","volume":"80","author":"Wei","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB68","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/1097-0215(20010120)95:1<34::AID-IJC1006>3.0.CO;2-V","article-title":"Loss of P16INK4A expression correlates with decreased survival in pediatric osteosarcomas","volume":"95","author":"Maitra","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB69","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0165-4608(96)00397-4","article-title":"Analysis of the p16INK4 and TP53 tumor suppressor genes in bone sarcoma pediatric patients","volume":"98","author":"Pati\u00f1o-Garc\u0131\u0301a","year":"1997","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB70","first-page":"115","article-title":"The p16 INK4a\/CDKN2A tumor suppressor and its relatives","volume":"1378","author":"Ruas","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB71","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1002\/1097-0142(20011215)92:12<3062::AID-CNCR10161>3.0.CO;2-X","article-title":"Involvement of INK4A gene products in the pathogenesis and development of human osteosarcoma","volume":"92","author":"Benassi","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB72","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0165-4608(01)00575-1","article-title":"Alterations of the INK4a\/ARF locus and their effects on the growth of human osteosarcoma cell lines","volume":"133","author":"Park","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB73","first-page":"2317","article-title":"Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutations","volume":"18","author":"Kanoe","year":"1998","journal-title":"Anticancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB74","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1525-1500.1999.09907.x","article-title":"Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma","volume":"23","author":"Ragazzini","year":"1999","journal-title":"Cancer Detect Prev"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB75","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/sj.onc.1201294","article-title":"Characterization of a highly conserved gene (OS4) amplified with CDK4 in human sarcomas","volume":"15","author":"Su","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB76","first-page":"545","article-title":"Mutation of cell cycle regulators: biological and clinical implications for human neoplasia","volume":"147","author":"Cordon-Cardo","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB77","first-page":"5535","article-title":"Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas","volume":"53","author":"Khatib","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB78","first-page":"6321","article-title":"CDKN2 (p16\/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas","volume":"54","author":"Schmidt","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB79","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/bjc.1995.344","article-title":"Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas-relationship to amplification and mRNA levels of CDK4 and CCND1","volume":"72","author":"Maelandsmo","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB80","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/(SICI)1098-2264(199612)17:4<205::AID-GCC2>3.0.CO;2-7","article-title":"Molecular cytogenetic characterization and physical mapping of 12q13\u201315 amplification in human cancers","volume":"17","author":"Elkahloun","year":"1996","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB81","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/path.1711750209","article-title":"MDM2 and CDK4 gene amplification in Ewing's sarcoma","volume":"175","author":"Ladanyi","year":"1995","journal-title":"J Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB82","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/(SICI)1098-2264(199612)17:4<254::AID-GCC7>3.0.CO;2-2","article-title":"Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas","volume":"17","author":"Berner","year":"1996","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB83","first-page":"5141","article-title":"Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4\/SAS and MDM2 as independent amplification targets","volume":"56","author":"Reifenberger","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB84","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1098-2264(199701)18:1<66::AID-GCC8>3.0.CO;2-#","article-title":"Complexity of 12q13\u201322 amplicon in liposarcoma: microsatellite repeat analysis","volume":"18","author":"Wolf","year":"1997","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB85","first-page":"1007","article-title":"Prognostic significance of cyclin expression in human osteosarcoma","volume":"12","author":"Molendini","year":"1998","journal-title":"Int J Oncol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB86","first-page":"150","article-title":"CDKN2\/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated","volume":"56","author":"Ueki","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB87","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/(SICI)1096-9896(199801)184:1<14::AID-PATH957>3.0.CO;2-K","article-title":"No p16INK4A\/CDKN2\/MTS1 mutations independent of P53 status in soft tissue sarcomas","volume":"184","author":"Meye","year":"1998","journal-title":"J Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB88","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/nar\/24.1.141","article-title":"Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation","volume":"24","author":"Hollstein","year":"1996","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB89","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/scbi.1998.0097","article-title":"Regulation of P53 downstream genes","volume":"8","author":"El-Deiry","year":"1998","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB90","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0165-4608(94)90154-6","article-title":"Cytogenetic aberrations in osteosarcomas: nonrandom deletions, rings, and double-minute chromosomes","volume":"77","author":"Fletcher","year":"1994","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB91","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/gcc.2870090203","article-title":"Chromosome analysis of nine osteosarcomas","volume":"9","author":"Hoogerwerf","year":"1994","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB92","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/17453674.1997.11744705","article-title":"p53: functions, mutations and sarcomas","volume":"273","author":"Hung","year":"1997","journal-title":"Acta Orthop Scand Suppl"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB93","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0959-437X(97)80108-6","article-title":"P53: from inductive signal to cellular effect","volume":"7","author":"Hansen","year":"1997","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB94","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-8674(00)81871-1","article-title":"P53, the cellular gatekeeper for growth and division","volume":"88","author":"Levine","year":"1997","journal-title":"Cell"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB95","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/bjc.1992.43","article-title":"Inactivation of p53 gene in human and murine osteosarcoma cells","volume":"65","author":"Chandar","year":"1992","journal-title":"Br J Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB96","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1128\/MCB.10.11.5772","article-title":"p53 functions as a cell cycle control protein in osteosarcomas","volume":"10","author":"Diller","year":"1990","journal-title":"Mol Cell Biol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB97","doi-asserted-by":"crossref","first-page":"7716","DOI":"10.1073\/pnas.84.21.7716","article-title":"Rearrangement of the p53 gene in human osteogenic sarcomas","volume":"84","author":"Masuda","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB98","first-page":"1483","article-title":"Identification and characterization of a p53 gene mutation in a human osteosarcoma cell line","volume":"4","author":"Romano","year":"1989","journal-title":"Oncogene"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB99","first-page":"7950","article-title":"Frequency and structure of p53 rearrangements in human osteosarcoma","volume":"50","author":"Miller","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB100","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0165-4608(95)00216-2","article-title":"Alterations of the p15, p16, and p18 genes in osteosarcoma","volume":"86","author":"Miller","year":"1996","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB101","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.1073\/pnas.87.15.5863","article-title":"Mechanisms of p53 loss in human sarcomas","volume":"87","author":"Mulligan","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB102","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/358080a0","article-title":"Amplification of a gene encoding a p53-associated protein in human sarcomas","volume":"358","author":"Oliner","year":"1992","journal-title":"Nature"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB103","first-page":"6194","article-title":"Mutation spectrum of the p53 gene in bone and soft tissue sarcomas","volume":"52","author":"Toguchida","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB104","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199205143262001","article-title":"Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma","volume":"326","author":"Toguchida","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB105","first-page":"468","article-title":"p53 abnormalities in different subtypes of human sarcomas","volume":"53","author":"Andreassen","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB106","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/humu.1380020407","article-title":"Screening for TP53 mutations in osteosarcomas using constant denaturant gel electrophoresis (CDGE)","volume":"2","author":"Smith-S\u00f8rensen","year":"1993","journal-title":"Hum Mutat"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB107","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/BF01229533","article-title":"Analysis of mutant P53 protein in osteosarcomas and other malignant and benign lesions of bone","volume":"119","author":"Ueda","year":"1993","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB108","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/bjc.1993.493","article-title":"Yamamuro T. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas","volume":"68","author":"Wadayama","year":"1993","journal-title":"Br J Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB109","first-page":"752","article-title":"P53 gene abnormalities in osteosarcoma","volume":"109","author":"Guo","year":"1996","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB110","first-page":"493","article-title":"Immunohistochemical detection of p53 protein overexpression in primary human osteosarcomas","volume":"17","author":"Bodey","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB111","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1541::AID-CNCR15>3.0.CO;2-Y","article-title":"p53 and MDM2 alterations in osteosarcomas: correlations with clinicopathologic features and proliferative rate","volume":"79","author":"Lonardo","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB112","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF02907805","article-title":"Allelic losses from chromosome 17 in human osteosarcomas","volume":"3","author":"Szt\u00e1n","year":"1997","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB113","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0046-8177(97)90224-0","article-title":"Analysis of p53 expression in osteosarcoma of the jaw: correlation with clinicopathologic and DNA ploidy findings","volume":"28","author":"Oliveira","year":"1997","journal-title":"Hum Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB114","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/S0046-8177(98)90263-5","article-title":"p53 gene mutations in osteosarcomas of low-grade malignancy","volume":"29","author":"Radig","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB115","first-page":"211","article-title":"p53 gene mutations in soft-tissue sarcomas - correlations with p53 immunohistochemistry and DNA ploidy","volume":"123","author":"Schneider-Stock","year":"1997","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB116","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0959-8049(95)00121-X","article-title":"Detection of TP53 gene mutations in human sarcomas","volume":"31A","author":"Castresana","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB117","first-page":"16","article-title":"MDM2 gene amplification in metastatic osteosarcoma","volume":"53","author":"Ladanyi","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB118","first-page":"1","article-title":"Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas","volume":"9","author":"Mousses","year":"1996","journal-title":"Mod Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0960-9822(00)00002-6","article-title":"Tumor spectrum analysis in P53-mutant mice","volume":"4","author":"Jacks","year":"1994","journal-title":"Curr Biol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB120","first-page":"5358","article-title":"A cancer family syndrome in twenty-four kindreds","volume":"48","author":"Li","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB121","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","article-title":"Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms","volume":"250","author":"Malkin","year":"1990","journal-title":"Science"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB122","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJM199205143262002","article-title":"Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms","volume":"326","author":"Malkin","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB123","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1302\/0301-620X.74B6.1447251","article-title":"A significant proportion of patients with osteosarcoma may belong to Li-Fraumeni cancer families","volume":"74","author":"Porter","year":"1992","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB124","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/348747a0","article-title":"Germ-line transmission of a mutated P53 gene in a cancer-prone family with Li-Fraumeni syndrome","volume":"348","author":"Srivastava","year":"1990","journal-title":"Nature"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB125","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1200\/JCO.1994.12.5.925","article-title":"Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma","volume":"12","author":"McIntyre","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB126","first-page":"1","article-title":"Tumors associated with p53 germline mutations: a synopsis of 91 families","volume":"150","author":"Kleihues","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB127","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/gcc.1207","article-title":"Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors","volume":"33","author":"Miller","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB128","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1126\/science.286.5449.2528","article-title":"Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome","volume":"286","author":"Bell","year":"1999","journal-title":"Science"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB129","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/1097-0142(20011015)92:8<2181::AID-CNCR1561>3.0.CO;2-3","article-title":"Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma","volume":"92","author":"Gokgoz","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB130","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1349-7006.1998.tb03295.x","article-title":"Association of loss of heterozygosity at the p53 locus with chemoresistance in osteosarcomas","volume":"89","author":"Goto","year":"1998","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB131","first-page":"205","article-title":"Antibodies to the retinoblastoma gene product detect specific loss of pp110RB in osteosarcomas and synovial sarcomas","volume":"1","author":"Shew","year":"1989","journal-title":"Oncogene Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB132","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/342705a0","article-title":"Mutations in p53 gene occur in diverse human tumour types","volume":"342","author":"Nigro","year":"1989","journal-title":"Nature (Lond)"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB133","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0165-4608(98)00026-0","article-title":"Correlation between apoptosis and TP53 status in osteosarcoma","volume":"105","author":"Pompetti","year":"1998","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB134","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/jnci\/86.17.1297","article-title":"MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status","volume":"86","author":"Fl\u00f8renes","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB135","first-page":"1","article-title":"Regulation of the p53 protein by the MDM2 oncoprotein: thirty-eighth G.H.A. Clowes Memorial Award Lecture","volume":"59","author":"Freedman","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB136","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1093\/nar\/26.15.3453","article-title":"The MDM2 gene amplification database","volume":"26","author":"Momand","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB137","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/362857a0","article-title":"Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53","volume":"362","author":"Oliner","year":"1993","journal-title":"Nature"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB138","first-page":"1065","article-title":"Mapping of amplification units in the q13\u201314 region of chromosome 12 in human sarcomas: some amplica do not include MDM2","volume":"4","author":"Forus","year":"1993","journal-title":"Cell Growth Differ"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB139","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/(SICI)1096-9896(199705)182:1<54::AID-PATH815>3.0.CO;2-I","article-title":"Point mutations and nucleotide insertions in the MDM2 zinc finger structure of human tumours","volume":"182","author":"Schlott","year":"1997","journal-title":"J Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB140","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/ijc.2910640511","article-title":"MDM2 gene amplification in bone and soft-tissue tumors: association with tumor progression in differentiated adipose-tissue tumors","volume":"64","author":"Nakayama","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB141","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0344-0338(98)80096-4","article-title":"Clinicopathologic implications of MDM2, p53 and K-ras gene alterations in osteosarcomas: MDM2 amplification and p53 mutations found in progressive tumors","volume":"194","author":"Yokoyama","year":"1998","journal-title":"Pathol Res Pract"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB142","article-title":"Multidrug resistance-associated protein (MRP) is expressed in osteosarcoma but is not a significant mechanism of drug resistance","author":"Kim","year":"2001","journal-title":"Trans Orthop Res Soc, Poster 0855"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB143","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/01.MP.0000024264.48690.EA","article-title":"Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years","volume":"15","author":"Kawaguchi","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB144","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/1097-0142(19950915)76:6<972::AID-CNCR2820760610>3.0.CO;2-T","article-title":"Osteosarcoma versus malignant fibrous histiocytoma of bone in patients older than 40 years: a clinicopathologic and immunohistochemical analysis with special reference to malignant fibrous histiocytoma-like osteosarcoma","volume":"76","author":"Naka","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB145","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0092-8674(95)90214-7","article-title":"Alternative reading frames of the INK4A tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest","volume":"83","author":"Quelle","year":"1995","journal-title":"Cell"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB146","first-page":"2041","article-title":"p16INK4A: a gene with a dual capacity to encode unrelated proteins that inhibit cell cycle progression","volume":"12","author":"Larsen","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB147","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0092-8674(00)80441-9","article-title":"Splicing into senescence: the curious case of p16 and p19ARF","volume":"91","author":"Haber","year":"1997","journal-title":"Cell"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB148","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0092-8674(00)81400-2","article-title":"The Ink4a tumor suppressor gene product, p16Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53","volume":"92","author":"Pomerantz","year":"1998","journal-title":"Cell"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB149","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0092-8674(00)81401-4","article-title":"ARF promotes MDM2 degradation and stabilizes P53: ARF-INK4A locus deletion impairs both the RB and P53 tumor suppression pathways","volume":"92","author":"Zhang","year":"1998","journal-title":"Cell"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB150","doi-asserted-by":"crossref","first-page":"6937","DOI":"10.1073\/pnas.96.12.6937","article-title":"P19(ARF) stabilizes P53 by blocking nucleo-cytoplasmic shuttling of MDM2","volume":"96","author":"Tao","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB151","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/sj.onc.1200976","article-title":"Differentiation induced by RB expression and apoptosis induced by p53 expression in an osteosarcoma cell line","volume":"14","author":"Ookawa","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB152","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1098-2264(199910)26:2<115::AID-GCC3>3.0.CO;2-E","article-title":"A novel chromosomal region of allelic loss, 4q32-q34, in human osteosarcomas revealed by representational difference analysis","volume":"26","author":"Simons","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB153","first-page":"106","article-title":"Localization of a novel tumor suppressor locus on human chromosome 3q important in osteosarcoma tumorigenesis","volume":"57","author":"Kruzelock","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB154","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/00001622-199807000-00009","article-title":"Osteosarcoma and other bone cancers","volume":"10","author":"Himelstein","year":"1998","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB155","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/bjc.1997.222","article-title":"Frequent reduction or loss of DCC gene expression in human osteosarcoma","volume":"75","author":"Horstmann","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB156","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1086\/302019","article-title":"Evidence for a novel osteosarcoma tumor-suppressor gene in the chromosome 18 region genetically linked with Paget disease of bone","volume":"63","author":"Nellissery","year":"1998","journal-title":"Am J Hum Genet"},{"issue":"suppl 2","key":"10.1016\/S0165-4608(03)00105-5_BIB157","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jbmr.5650140209","article-title":"Common mechanisms of osteosarcoma and Paget's disease","volume":"14","author":"Hansen","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB158","doi-asserted-by":"crossref","first-page":"5975","DOI":"10.1038\/sj.onc.1205764","article-title":"Two novel tumor suppressor gene loci on chromosome 6q and 15q in human osteosarcoma identified through comparative study of allelic imbalances in mouse and man","volume":"21","author":"Nathrath","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB159","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0303-7207(01)00456-7","article-title":"Microarray analysis of Tbx2-directed gene expression: a possible role in osteogenesis","volume":"177","author":"Chen","year":"2001","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB160","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0925-4773(00)00494-9","article-title":"Cloning and expression analysis of the mouse T-box gene Tbx18","volume":"100","author":"Kraus","year":"2001","journal-title":"Mech Dev"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-4608(96)00109-4","article-title":"Amplification of a rearranged form of the high-mobility group protein gene HMGIC in OsA-CI osteosarcoma cells","volume":"91","author":"Kools","year":"1996","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB162","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1038\/sj.onc.1201135","article-title":"HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas","volume":"14","author":"Berner","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB163","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/modpathol.3880308","article-title":"The tumor-associated gene HMGIC is expressed in normal and osteoarthritis-affected synovia","volume":"14","author":"Broberg","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB164","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng0895-436","article-title":"Recurrent rearrangements of the high mobility protein gene, HMGI-C, in benign mesenchymal tumours","volume":"10","author":"Schoenmakers","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB165","first-page":"527","article-title":"SV40-like sequences in human bone tumors","volume":"13","author":"Carbone","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB166","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/jnci\/91.2.119","article-title":"Cell and molecular biology of simian virus 40: implications for human infections and disease","volume":"91","author":"Butel","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB167","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1038\/sj.onc.1202179","volume":"17","author":"Mendoza","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB168","first-page":"4299","article-title":"Amplification of multiple genes from chromosomal region 12q13\u201314 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, MDM2","volume":"54","author":"Reifenberger","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB169","first-page":"5407","article-title":"Amplification of the GLI gene in childhood sarcomas","volume":"49","author":"Roberts","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB170","first-page":"495","article-title":"Identification and cloning of a novel amplified DNA sequence in human malignant fibrous histiocytoma derived from a region of chromosome 12 frequently rearranged in soft tissue tumors","volume":"2","author":"Meltzer","year":"1991","journal-title":"Cell Growth Differ"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB171","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/(SICI)1098-2744(199604)15:4<270::AID-MC4>3.0.CO;2-K","article-title":"Complete sequence analysis of a gene (OS-9) ubiquitously expressed in human tissues and amplified in sarcomas","volume":"15","author":"Su","year":"1996","journal-title":"Mol Carcinog"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB172","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/(SICI)1098-2264(199909)26:1<62::AID-GCC9>3.0.CO;2-F","article-title":"Amplifications of DNA primase I (PRIM1) in human osteosarcoma","volume":"26","author":"Yotov","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB173","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1006\/geno.1997.4727","article-title":"Transcript mapping in a 46-kb sequenced region at the core of 12q13.3 amplification in human cancers","volume":"42","author":"Elkahloun","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB174","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/bjc.1998.521","article-title":"Molecular characterization of a novel amplicon at 1q21-q22 frequently observed in human sarcomas","volume":"78","author":"Forus","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/gcc.2870140104","article-title":"Comparative genomic hybridization analysis of human sarcomas:","volume":"14","author":"Forus","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB176","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/(SICI)1097-0215(19990420)84:2<114::AID-IJC4>3.0.CO;2-Q","article-title":"DNA sequence copy number increase at 8q: a potential new prognostic marker in high-grade osteosarcoma","volume":"84","author":"Tarkkanen","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB177","first-page":"6247","article-title":"Assignment of common allele loss in osteosarcoma to the subregion 17p13","volume":"49","author":"Toguchida","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB178","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/(SICI)1098-2264(199704)18:4<279::AID-GCC5>3.0.CO;2-Y","article-title":"Malignant astrocytoma-derived region of common amplification in chromosomal band 17p12 is frequently amplified in high-grade osteosarcomas","volume":"18","author":"Hulsebos","year":"1997","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB179","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/(SICI)1098-2264(199710)20:2<196::AID-GCC10>3.0.CO;2-P","article-title":"Isolation of osteosarcoma-associated amplified DNA sequences using representational difference analysis","volume":"20","author":"Simons","year":"1997","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB180","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1038\/sj.onc.1202748","article-title":"The MYC oncoprotein: a critical evaluation of transactivation and target gene regulation","volume":"18","author":"Cole","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB181","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1038\/sj.onc.1202746","article-title":"MYC oncogenes and human neoplastic disease","volume":"18","author":"Nesbit","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB182","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/(SICI)1097-4644(199610)63:1<37::AID-JCB3>3.0.CO;2-0","article-title":"Oncogene alterations in primary, recurrent, and metastatic human bone tumors","volume":"63","author":"Pompetti","year":"1996","journal-title":"J Cell Biochem"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB183","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/jor.1100110410","article-title":"Amplification of c-myc oncogene and absence of c-Ha-ras point mutation in human bone sarcoma","volume":"11","author":"Barrios","year":"1993","journal-title":"J Orthop Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB184","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00000421-199406000-00019","article-title":"Clinicopathologic correlations and short-term prognosis in musculoskeletal sarcoma with c-myc oncogene amplification","volume":"17","author":"Barrios","year":"1994","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB185","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00019606-199309000-00004","article-title":"Sporadic amplification of the MYC gene in human osteosarcomas","volume":"2","author":"Ladanyi","year":"1993","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB186","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/13577149778209","article-title":"Amplification of the MYC gene in osteosarcoma arising in Paget's disease","volume":"1","author":"Ueda","year":"1998","journal-title":"Sarcoma"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB187","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1159\/000011912","article-title":"C-myc and c-fos in human osteosarcoma: prognostic value of mRNA and protein expression","volume":"55","author":"Gamberi","year":"1998","journal-title":"Oncology"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB188","first-page":"861","article-title":"FOS expression induces bone tumors in transgenic mice","volume":"4","author":"Ruther","year":"1989","journal-title":"Oncogene"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB189","first-page":"6244","article-title":"C-fos-induced osteosarcoma formation in transgenic mice: cooperativity with c-jun and the role of endogenous c-fos","volume":"55","author":"Wang","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB190","first-page":"989","article-title":"The proto-oncogene c-fos is over-expressed in the majority of human osteosarcomas","volume":"5","author":"Wu","year":"1990","journal-title":"Oncogene"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB191","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s004280050199","article-title":"Immunohistochemical detection of c-fos and c-jun expression in osseous and cartilaginous tumours of the skeleton","volume":"432","author":"Franchi","year":"1998","journal-title":"Virchows Arch"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB192","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/(SICI)1096-9098(200002)73:2<125::AID-JSO14>3.0.CO;2-5","article-title":"Correlation of c-fos, p53, and PCNA expression with treatment outcome in osteosarcoma","volume":"73","author":"Kakar","year":"2000","journal-title":"J Surg Oncol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB193","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/(SICI)1097-0142(19960101)77:1<71::AID-CNCR13>3.0.CO;2-5","article-title":"ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma","volume":"77","author":"Onda","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB194","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/1097-0142(20010801)92:3<677::AID-CNCR1370>3.0.CO;2-V","article-title":"Amplification of the HER-2\/neu oncogene is uncommon in pediatric osteosarcomas","volume":"92","author":"Maitra","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB195","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1200\/JCO.1999.17.9.2781","article-title":"Expression of HER2\/erbB-2 correlates with survival in osteosarcoma","volume":"17","author":"Gorlick","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB196","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/cncr.10360","article-title":"ErbB2 expression is correlated with increased survival of patients with osteosarcoma","volume":"94","author":"Akatsuka","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB197","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/modpathol.3880474","article-title":"Clinicopathologic analysis of HER-2\/neu immunoexpression among various histologic subtypes and grades of osteosarcoma","volume":"14","author":"Kilpatrick","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB198","first-page":"19A","article-title":"HER-2\/neu staining in osteosarcoma: association with increased risk of metastasis","volume":"14","author":"Zhou","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB199","first-page":"788","article-title":"Absence of HER\/neu gene expression in osteosarcoma and skeletal Ewing's sarcoma","volume":"8","author":"Thomas","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB200","first-page":"5355","article-title":"Met expression and sarcoma tumorigenicity","volume":"53","author":"Rong","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB201","first-page":"739","article-title":"The Met\/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit","volume":"10","author":"Ferracini","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB202","first-page":"1209","article-title":"Expression of Met\/hepatocyte growth factor receptor gene and malignant behavior of musculoskeletal tumors","volume":"149","author":"Scotlandi","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB203","first-page":"832","article-title":"Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors","volume":"10","author":"Naka","year":"1997","journal-title":"Mod Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB204","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/(SICI)1096-9098(199809)69:1<21::AID-JSO5>3.0.CO;2-M","article-title":"Expression of insulin-like growth factor receptor, IGF-1, and IGF-2 in primary and metastatic osteosarcoma","volume":"69","author":"Burrow","year":"1998","journal-title":"J Surg Oncol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB205","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/(SICI)1097-0215(19990209)80:4<581::AID-IJC16>3.0.CO;2-O","article-title":"Redundancy of autocrine loops in human osteosarcoma cells","volume":"80","author":"Benini","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB206","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1074\/jbc.272.7.4483","article-title":"Accumulation of E2F-4 DP-1 DNA binding complexes correlates with induction of dhfr gene expression during the G1 to S phase transition","volume":"272","author":"Wells","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB207","first-page":"621","article-title":"Mechanisms of methotrexate resistance in osteosarcoma","volume":"5","author":"Guo","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB208","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF03000485","article-title":"Topoisomerases, new targets in cancer chemotherapy","volume":"7","author":"Zijlstra","year":"1990","journal-title":"Med Oncol Tumor Pharmacother"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB209","first-page":"357","article-title":"Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs","volume":"54","author":"Grant","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB210","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1056\/NEJM199511233332103","article-title":"Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome","volume":"333","author":"Baldini","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB211","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/jor.1100170502","article-title":"P-glycoprotein expression in osteosarcoma: a basis for risk-adapted adjuvant chemotherapy","volume":"17","author":"Baldini","year":"1999","journal-title":"J Orthop Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB212","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/0959-8049(96)00046-9","article-title":"Biology of the multidrug resistance-associated protein, MRP","volume":"32A","author":"Loe","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB213","first-page":"2434","article-title":"Multidrug resistance and malignancy in human osteosarcoma","volume":"56","author":"Scotlandi","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB214","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/sj.onc.1202330","article-title":"The expression of P-glycoprotein is causally related to a less aggressive phenotype in human osteosarcoma cells","volume":"18","author":"Scotlandi","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB215","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/jnci\/89.22.1706","article-title":"P-glycoprotein expression: critical determinant in the response to osteosarcoma chemotherapy","volume":"89","author":"Chan","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB216","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.1073\/pnas.92.12.5436","article-title":"Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes and apoptosis","volume":"92","author":"Almasan","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB217","first-page":"4292","article-title":"Role of E2F-1 in chemosensitivity","volume":"58","author":"Banerjee","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB218","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/jnci\/88.18.1269","article-title":"Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line","volume":"88","author":"Hochhauser","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB219","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1126\/science.7973635","article-title":"p53 status and the efficacy of cancer therapy in vivo","volume":"266","author":"Lowe","year":"1994","journal-title":"Science"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB220","first-page":"1405","article-title":"Transfection of wild-type but not mutant P53 induces early monocytic differentiation in HL60 cells and increases their sensitivity to stress","volume":"6","author":"Banerjee","year":"1995","journal-title":"Cell Growth Differ"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB221","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0092-8674(92)90243-6","article-title":"Altered cell cycle arrest and gene amplification potential accompany loss of wild-type P53","volume":"70","author":"Livingstone","year":"1992","journal-title":"Cell"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB222","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/0092-8674(92)90244-7","article-title":"Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles","volume":"70","author":"Yin","year":"1992","journal-title":"Cell"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB223","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1021\/bi00294a015","article-title":"Amplification and organization of dihydrofolate reductase genes in a human leukemia cell line, K-562, resistant to methotrexate","volume":"22","author":"Srimatkandada","year":"1983","journal-title":"Biochemistry"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB224","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1096\/fasebj.4.8.2185970","article-title":"Dihydrofolate reductase as a therapeutic target","volume":"4","author":"Schweitzer","year":"1990","journal-title":"FASEB J"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB225","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/030089168707300402","article-title":"Prognostic value of serum alkaline phosphatase in osteosarcoma","volume":"73","author":"Bacci","year":"1987","journal-title":"Tumori"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB226","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/1120009X.1994.11741153","article-title":"Prognostic significance of serum lactate dehydrogenase in patients with osteosarcoma of the extremities","volume":"6","author":"Bacci","year":"1994","journal-title":"J Chemother"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB227","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/1097-0142(19880201)61:3<569::AID-CNCR2820610324>3.0.CO;2-Z","article-title":"Prognostic significance of bone morphogenetic activity in osteosarcoma tissue","volume":"61","author":"Yoshikawa","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB228","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.20.3.776","article-title":"Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols","volume":"20","author":"Bielack","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB229","first-page":"14","article-title":"Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy, en block resection and prosthetic bone replacement","volume":"101","author":"Huvos","year":"1977","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB230","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/1097-0142(19820315)49:6<1221::AID-CNCR2820490625>3.0.CO;2-E","article-title":"Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy","volume":"49","author":"Rosen","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB231","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1200\/JCO.1998.16.7.2452","article-title":"Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol","volume":"16","author":"Meyers","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB232","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/hupa.2001.25585","article-title":"Rosette-forming epithelioid osteosarcoma: a histologic subtype with highly aggressive clinical behavior","volume":"32","author":"Okada","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB233","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1200\/JCO.2002.20.3.627","article-title":"Prognostic factors for sarcomas: hard and soft","volume":"20","author":"Meyers","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB234","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/bjc.1996.487","article-title":"Quantitative analysis of multidrug resistance gene expression in human osteosarcomas","volume":"74","author":"Lee","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB235","first-page":"317","article-title":"P-glycoprotein expression in high grade central osteosarcoma and normal bone cells: an immunohistochemical study","volume":"142","author":"P\u00f6sl","year":"1997","journal-title":"Gen Diagn Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB236","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/bjc.1998.573","article-title":"P-glycoprotein and metallothionein expression and resistance to chemotherapy in osteosarcoma","volume":"78","author":"Shnyder","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB237","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1200\/JCO.2000.18.14.2685","article-title":"MDR1 gene expression and outcome in osteosarcoma: a prospective, multicenter study","volume":"18","author":"Wunder","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB238","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJM199605163342014","article-title":"p-glycoprotein and multidrug resistance","volume":"334","author":"Mesa-Tejada","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB239","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00019606-199503000-00011","article-title":"Correlation of p-glycoprotein detection by immunohistochemistry with mdr-1 mRNA levels in osteosarcomas: pilot study","volume":"4","author":"Kandel","year":"1995","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB240","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0959-8049(95)00478-5","article-title":"MDR1 gene expression: evaluation of its use as a molecular marker for prognosis and chemotherapy of bone and soft tissue sarcomas","volume":"32A","author":"Stein","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB241","first-page":"3010","article-title":"Methods to detect p-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations","volume":"56","author":"Beck","year":"1996","journal-title":"Cancer Res"},{"issue":"4 suppl 5","key":"10.1016\/S0165-4608(03)00105-5_BIB242","first-page":"63","article-title":"Measuring multidrug resistance expression in human malignancies: elaboration of consensus recommendations","volume":"34","author":"Marie","year":"1997","journal-title":"Semin Hematol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB243","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/sj.leu.2400691","article-title":"Multidrug resistance in acute leukemia: a comparison of different diagnostic methods","volume":"11","author":"Pall","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB244","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0304-3835(99)00018-X","article-title":"Relationship between P-glycoprotein positivity, doxorubicin binding ability and histologic response to chemotherapy in osteosarcomas","volume":"138","author":"Kusuzaki","year":"1999","journal-title":"Cancer Lett"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB245","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0165-4608(99)00255-1","article-title":"Analysis of the p16INK4, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma","volume":"120","author":"Tsuchiya","year":"2000","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB246","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/1097-0142(19821201)50:11<2476::AID-CNCR2820501136>3.0.CO;2-N","article-title":"Cellular DNA content in human osteosarcoma: aspects on diagnosis and prognosis","volume":"50","author":"Kreicbergs","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB247","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/1097-0142(19840101)53:1<129::AID-CNCR2820530123>3.0.CO;2-O","article-title":"Flow DNA analysis of primary bone tumors: relationship between cellular DNA content and histopathologic classification","volume":"53","author":"Kreicbergs","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB248","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0304-3835(98)00336-X","article-title":"Prognostic significance of DNA ploidy pattern in osteosarcomas in association with chemotherapy","volume":"137","author":"Kusuzaki","year":"1999","journal-title":"Cancer Lett"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB249","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00003086-199908000-00023","article-title":"Expression of bone morphogenetic proteins and their receptors in sarcomas","volume":"365","author":"Guo","year":"1999","journal-title":"Clin Orthop"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB250","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/(SICI)1097-0215(19980619)79:3<245::AID-IJC6>3.0.CO;2-P","article-title":"Expression of the smooth muscle calponin gene in human osteosarcoma and its possible association with prognosis","volume":"79","author":"Yamamura","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB251","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/1097-0142(19950201)75:3<806::AID-CNCR2820750310>3.0.CO;2-S","article-title":"Clinical relevance of Ki-67 expression in bone tumors","volume":"75","author":"Scotlandi","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB252","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12<2230::AID-CNCR3>3.3.CO;2-V","article-title":"Expression of transforming growth factor-\u03b2 (TGF-\u03b2) isoforms in osteosarcomas: TGF-\u03b23 is related to disease progression","volume":"80","author":"Kloen","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB253","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2336::AID-CNCR7>3.0.CO;2-J","article-title":"Overexpression of resistance-related proteins (metallothioneins, glutathione-S-transferase \u03c0, heat shock protein 27, and lung resistance-related protein) in osteosarcoma","volume":"79","author":"Uozaki","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB254","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1040-8428(01)00188-3","article-title":"Telomerase in cancer and aging","volume":"41","author":"Granger","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB255","first-page":"3166","article-title":"Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors: correlation with grade, histology, and proliferative activity","volume":"59","author":"Yan","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB256","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/BF02303833","article-title":"Telomerase activity in skeletal sarcomas","volume":"5","author":"Aue","year":"1998","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB257","first-page":"1759","article-title":"Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma","volume":"63","author":"Ulaner","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB258","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/1097-0215(20010520)95:3<156::AID-IJC1027>3.0.CO;2-L","article-title":"Presence of telomerase activity in different musculoskeletal tumor histotypes and correlation with aggressiveness","volume":"95","author":"Sangiorgi","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB259","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0344-0338(99)80117-4","article-title":"Telomerase activity in benign bone tumors and tumor-like lesions","volume":"195","author":"Kido","year":"1999","journal-title":"Pathol Res Pract"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB260","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0165-4608(89)90169-6","article-title":"Complex karyotypes in a series of pediatric osteosarcomas","volume":"38","author":"Biegel","year":"1989","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB261","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/ijc.2910550109","article-title":"Cytogenetic findings in 33 osteosarcomas","volume":"55","author":"Mertens","year":"1993","journal-title":"Int J Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB262","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0165-4608(96)00306-8","article-title":"Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature","volume":"95","author":"Bridge","year":"1997","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB263","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0165-4608(91)90113-9","article-title":"Complete association of loss of heterozygosity of chromosomes 13 and 17 in osteosarcoma","volume":"53","author":"Scheffer","year":"1991","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB264","first-page":"1161","article-title":"Eleventh International Workshop on Human Gene Mapping. London, UK, August 18\u201322, 1991","volume":"58","author":"Human gene mapping 11. London Conference (1991)","year":"1991","journal-title":"Cytogenet Cell Genet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB265","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000133416","article-title":"Report of the first international workshop on human chromosome 12 mapping","volume":"61","author":"Craig","year":"1992","journal-title":"Cytogenet Cell Genet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB266","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/clinchem\/41.11.1554","article-title":"Fluorescence in situ hybridization: powerful molecular tool for cancer prognosis","volume":"41","author":"Fox","year":"1995","journal-title":"Clin Chem"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB267","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1002\/1097-0142(19941015)74:8<2268::AID-CNCR2820740810>3.0.CO;2-5","article-title":"Cytogenetic findings in 19 malignant bone tumors","volume":"74","author":"Ozisik","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB268","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/adc.63.9.1012","article-title":"Cytogenetic investigations of solid tumours of children","volume":"63","author":"Pearson","year":"1988","journal-title":"Arch Dis Child"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB269","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0165-4608(98)00073-9","article-title":"Inversion (6)(p23q15) as the sole anomaly in a low-grade intraosseous osteosarcoma","volume":"109","author":"Grubb","year":"1999","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB270","first-page":"11A","article-title":"Utility of fine needle aspiration in the diagnosis of primary osteosarcoma","volume":"14","author":"Dodd","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB271","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/(SICI)1097-0339(199607)15:1<17::AID-DC5>3.0.CO;2-N","article-title":"Cytogenetic studies on fine\u2013needle aspiration samples from osteosarcoma and Ewing's sarcoma","volume":"15","author":"\u00c5kerman","year":"1996","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB272","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/(SICI)1097-0320(19960915)26:3<185::AID-CYTO1>3.0.CO;2-E","article-title":"Comparison of cytogenetic, interphase cytogenetics, and DNA flow cytometry in bone tumors","volume":"26","author":"Tarkkanen","year":"1996","journal-title":"Cytometry"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB273","doi-asserted-by":"crossref","DOI":"10.1016\/S0165-4608(02)00929-9","article-title":"Chromosomal instability (CIN) in osteosarcoma and its association with centrosome abnormalities","author":"Al\u2013Romaih","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB274","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/gcc.2870100403","article-title":"Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors","volume":"10","author":"Kallioniemi","year":"1994","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB275","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/cyto.990190104","article-title":"Computer image analysis of comparative genomic hybridization","volume":"19","author":"Piper","year":"1995","journal-title":"Cytometry"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB276","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/(SICI)1098-2264(199802)21:2<172::AID-GCC14>3.0.CO;2-T","article-title":"Minimal sizes of deletions detected by comparative genomic hybridization","volume":"21","author":"Bentz","year":"1998","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB277","first-page":"1211","article-title":"Comparative genomic hybridization in clinical cytogenetics","volume":"57","author":"Bryndorf","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB278","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/1098-2264(200007)28:3<329::AID-GCC11>3.0.CO;2-F","article-title":"Chromosomal regions involved in the pathogenesis of osteosarcomas","volume":"28","author":"Stock","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB279","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/cyto.1068","article-title":"DNA copy number amplifications in sarcomas with homogeneously staining regions and double minutes","volume":"46","author":"Menghi-Sartorio","year":"2001","journal-title":"Cytometry"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB280","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0165-4608(01)00461-7","article-title":"Comparative genomic hybridization analysis identifies gains of 1p35\u223cp36 and chromosome 19 in osteosarcoma","volume":"130","author":"Zielenska","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB281","first-page":"1334","article-title":"Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization","volume":"55","author":"Tarkkanen","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB282","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/bjc.1996.380","article-title":"No evidence of microsatellite instability in bone tumours","volume":"74","author":"Tarkkanen","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB283","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0165-4608(96)00241-5","article-title":"Molecular cytogenetics of bone and soft tissue tumors","volume":"95","author":"van Kessel","year":"1997","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB284","first-page":"184","article-title":"Novel amplicons in high-grade osteosarcomas detected by comparative genomic hybridization (CGH)","volume":"82","author":"Brinkschmidt","year":"1998","journal-title":"Verh Dtsch Ges Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB285","first-page":"421","article-title":"Comparative genomic hybridization of low-grade central osteosarcoma","volume":"11","author":"Tarkkanen","year":"1998","journal-title":"Mod Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB286","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/ijc.10709","article-title":"Genetic imbalances revealed by comparative genomic hybridization in osteosarcomas","volume":"102","author":"Ozaki","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB287","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/gcc.2870140103","article-title":"Comparative genomic hybridization analysis of human sarcomas:","volume":"14","author":"Forus","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB288","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/(SICI)1097-0215(19990730)82:3<329::AID-IJC4>3.0.CO;2-1","article-title":"Characterization of the 17p amplicon in human sarcomas: microsatellite marker analysis","volume":"82","author":"Wolf","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB289","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0165-4608(02)00627-1","article-title":"Amplification of 17p11.2-p12, including PMP22, TOP3A, and MAPK7 in high-grade osteosarcoma","volume":"139","author":"van Dartel","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB290","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/gcc.10132","article-title":"Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas","volume":"36","author":"Bayani","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB291","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/(SICI)1098-2264(199811)23:3<203::AID-GCC1>3.0.CO;2-5","article-title":"Chromosomal organization of amplified chromosome 12 sequences in mesenchymal tumors detected by fluorescence in situ hybridization","volume":"23","author":"Gisselsson","year":"1998","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB292","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/gcc.1219","article-title":"Differentially amplified chromosome 12 sequences in low- and high-grade osteosarcoma","volume":"33","author":"Gisselsson","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB293","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0165-4608(98)00072-7","article-title":"Aberrations of chromosomes 1 and 17 in six human osteosarcoma cell lines using double-target fluorescence in situ hybridization","volume":"107","author":"Murata","year":"1998","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB294","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0304-3835(99)00042-7","article-title":"Relationship between chromosomal aberrations by fluorescence in situ hybridization and DNA ploidy by cytofluorometry in osteosarcoma","volume":"139","author":"Murata","year":"1999","journal-title":"Cancer Lett"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB295","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jor.1100130506","article-title":"Osteosarcoma oncogene expression detected by in situ hybridization","volume":"13","author":"Wang","year":"1995","journal-title":"J Orthop Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB296","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0165-4608(00)00319-8","article-title":"Novel findings in gene expression detected in human osteosarcoma by cDNA microarray","volume":"123","author":"Wolf","year":"2000","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB297","first-page":"59","article-title":"Molecular profiling of sarcomas: microarray analysis of osteosarcomas and isolation of three novel candidate genes from 1q21 amplicon","volume":"128","author":"Forus","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB298","article-title":"Expression profiling of osteogenic sarcoma: a potential diagnostic and prognostic tool","author":"Siegel","year":"2002","journal-title":"Trans Orthop Res Soc"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB299","series-title":"Expression profiling of human tumors: diagnostic and research applications","article-title":"Expression profiling of bone tumors","author":"Schofield","year":"2003"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB300","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0165-4608(92)90038-A","article-title":"Ring chromosome in parosteal osteosarcoma: clinical and diagnostic significance","volume":"62","author":"Sinovic","year":"1992","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB301","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/(SICI)1098-2264(199605)16:1<31::AID-GCC4>3.0.CO;2-4","article-title":"Ring chromosomes in parosteal osteosarcoma contain sequences from 12q13\u201315: a combined cytogenetic and comparative genomic hybridization study","volume":"16","author":"Szymanska","year":"1996","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB302","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/1097-0142(197605)37:5<2466::AID-CNCR2820370540>3.0.CO;2-G","article-title":"Parosteal osteosarcoma","volume":"37","author":"Unni","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB303","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/(SICI)1097-0142(19961115)78:10<2136::AID-CNCR14>3.0.CO;2-#","article-title":"Conventional and dedifferentiated parosteal osteosarcoma: diagnosis, treatment, and outcome","volume":"78","author":"Sheth","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB304","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2559.1995.tb00290.x","article-title":"Giant cell rich parosteal osteosarcoma","volume":"27","author":"Sciot","year":"1995","journal-title":"Histopathology"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB305","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/jor.1100140504","article-title":"SAS is amplified predominantly in surface osteosarcoma","volume":"14","author":"Noble-Topham","year":"1996","journal-title":"J Orthop Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB306","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/sj.onc.1202346","article-title":"Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas","volume":"18","author":"Wunder","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB307","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00003086-200008000-00026","article-title":"Analysis of 12q13\u201315 genes in parosteal osteosarcoma","volume":"377","author":"Gamberi","year":"2000","journal-title":"Clin Orthop"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB308","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1200\/JCO.20.2.521","article-title":"Extraosseous osteosarcoma: response to treatment and long-term outcome","volume":"20","author":"Ahmad","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB309","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/00000478-199805000-00010","article-title":"Extraskeletal osteosarcomas: a clinicopathologic study of 25 cases","volume":"22","author":"Jensen","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB310","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-4608(96)00434-7","article-title":"Cytogenetic aberrations and DNA ploidy in soft tissue sarcoma: a Southwest Oncology Group Study","volume":"99","author":"Mohamed","year":"1997","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB311","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1098-2264(199805)22:1<16::AID-GCC3>3.0.CO;2-A","article-title":"Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP study group","volume":"22","author":"Mertens","year":"1998","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB312","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1359\/jbmr.1998.13.6.911","article-title":"Paget's disease of bone: evidence for a susceptibility locus on chromosome 18q and for genetic heterogeneity","volume":"13","author":"Haslam","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB313","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0889-8529(18)30048-3","article-title":"Diagnostic procedures for Paget disease","volume":"24","author":"Klein","year":"1995","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB314","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1525-1578(10)60669-1","article-title":"Inheritance of osteosarcoma and Paget's disease of bone: a familial loss of heterozygosity study","volume":"3","author":"McNairn","year":"2001","journal-title":"J Mol Diagn"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB315","first-page":"211","article-title":"Inheritance of Paget's osteosarcoma: TNFRSF11A (rank) T311T; 933G > A: a not so silent mutation?","volume":"3","author":"Shrimpton","year":"2001","journal-title":"J Med Diagn"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB316","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/71667","article-title":"Mutations of TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis","volume":"24","author":"Hughes","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB317","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S8756-3282(00)00411-7","article-title":"Evaluation of the role of RANK and OPG genes in Paget's disease of bone","volume":"28","author":"Wuyts","year":"2001","journal-title":"Bone"},{"issue":"suppl 2","key":"10.1016\/S0165-4608(03)00105-5_BIB318","first-page":"21","article-title":"A putative role for c-Fos in the pathophysiology of Paget's disease","volume":"14","author":"Beedles","year":"1994","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB319","article-title":"Inheritance of Paget's osteosarcoma of bone: a loss of heterozygosity study","author":"Damron","year":"2002","journal-title":"Trans Orthop Res Soc"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB320","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s002230001211","article-title":"Mutation screening of the TNFRSF11A gene encoding receptor activator of NF kappa B (RANK) in familial and sporadic Paget's disease of bone and osteosarcoma","volume":"68","author":"Sparks","year":"2001","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB321","first-page":"5518","article-title":"Genetics of cancer predisposition","volume":"47","author":"Hansen","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB322","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/modpathol.3880377","article-title":"Simultaneous paired analysis of numerical chromosomal aberrations and DNA content in osteosarcoma","volume":"14","author":"Serra","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB323","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3109\/17453679008993520","article-title":"DNA cytometry of musculoskeletal tumors: a review","volume":"61","author":"Kreicbergs","year":"1990","journal-title":"Acta Orthop Scand"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB324","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/cyto.990190309","article-title":"DNA and RNA content analysis by flow cytometry in the pathobiologic assessment of bone tumors","volume":"19","author":"El-Naggar","year":"1995","journal-title":"Cytometry"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB325","first-page":"461","article-title":"Prognostic significance of DNA image cytophotometry for osteosarcoma","volume":"21","author":"Neuburger","year":"1999","journal-title":"Anal Quant Cytol Histol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB326","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/cncr.10258.abs","article-title":"Osteosarcoma of the spine: experience of the Cooperative Osteosarcoma Study Group","volume":"94","author":"Ozaki","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB327","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/labinvest.3780431","article-title":"Cytogenetics and molecular biology of osteosarcoma","volume":"82","author":"Ragland","year":"2002","journal-title":"Lab Invest"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB328","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1002\/1097-0142(19880615)61:12<2532::AID-CNCR2820611224>3.0.CO;2-H","article-title":"DNA analysis in the differential diagnosis of osteosarcoma","volume":"61","author":"Bauer","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB329","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/17453678909149293","article-title":"Prognostication including DNA analysis in osteosarcoma","volume":"60","author":"Bauer","year":"1989","journal-title":"Acta Orthop Scand"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB330","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/1097-0142(19870115)59:2<324::AID-CNCR2820590226>3.0.CO;2-9","article-title":"Tumor heterogeneity in osteosarcoma as identified by flow cytometry","volume":"59","author":"Hiddemann","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB331","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00003086-199109000-00024","article-title":"Flow cytometric studies of human osteosarcoma","volume":"270","author":"Mankin","year":"1991","journal-title":"Clin Orthop"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB332","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/00001622-200207000-00007","article-title":"cDNA microarray analysis of global gene expression in sarcomas","volume":"14","author":"Schofield","year":"2002","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB333","article-title":"In vivo inhibition of osteosarcoma pulmonary metastasis with bystander effect using gene therapy","author":"Seto","year":"2002","journal-title":"Trans Orthop Res Soc"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB334","first-page":"3584","article-title":"Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571","volume":"8","author":"McGary","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB335","article-title":"Nuclear receptor agonists as effective differentiation therapy agents for human osteosarcoma","author":"Haydon","year":"2002","journal-title":"Trans Orthop Res Soc"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB336","series-title":"Bone tumors: diagnosis, treatment, and prognosis","author":"Huvos","year":"1991"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB337","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/bjc.1998.496","article-title":"Osteoid osteoma and osteoblastoma with clonal chromosome changes","volume":"78","author":"Dal Cin","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB338","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0165-4608(00)00327-7","article-title":"Osteoid osteomas with chromosome alterations involving 22q","volume":"124","author":"Baruffi","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB339","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/15227950050193597","article-title":"Osteoblastoma: a mimic of osteosarcoma","volume":"19","author":"Rosado","year":"2000","journal-title":"Pediatr Pathol Mol Med"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB340","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1001\/archsurg.1932.01160160022002","article-title":"An osteoblastic osteoid tissue-forming tumor of metacarpal bone","volume":"24","author":"Jaffe","year":"1932","journal-title":"Arch Surg"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB341","first-page":"141","article-title":"Benign osteoblastoma","volume":"17","author":"Jaffe","year":"1956","journal-title":"Bull Hosp Jt Dis Orthop Inst"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB342","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/1097-0142(195609\/10)9:5<1044::AID-CNCR2820090523>3.0.CO;2-O","article-title":"Benign osteoblastoma: a category of osteoid and bone forming tumors other than the classical osteoid osteoma, which may be mistaken for giant cell tumor or osteogenic sarcoma","volume":"9","author":"Lichtenstein","year":"1956","journal-title":"Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB343","series-title":"Dahlin's bone tumors: general aspects and data on 11087 cases","author":"Unni","year":"1996"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB344","series-title":"Tumors of bones and joints: atlas of tumor pathology. 3rd series, fascicle 8","author":"Fechner","year":"1993"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB345","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/00000478-199607000-00007","article-title":"Osteoblastoma: varied histological presentations with a benign clinical course, an analysis of 55 cases","volume":"20","author":"Della Rocca","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB346","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0046-8177(99)90046-1","article-title":"Large cell, epithelioid, telangiectatic osteoblastoma: a unique pseudosarcomatous variant of osteoblastoma","volume":"30","author":"Angervall","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB347","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/(SICI)1096-9896(199807)185:3<284::AID-PATH94>3.0.CO;2-Z","article-title":"Expression of transforming growth factor \u03b2 isoforms in osteosarcoma variants: association of TGF\u03b2 with high-grade osteosarcomas","volume":"185","author":"Franchi","year":"1998","journal-title":"J Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB348","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0344-0338(98)80125-8","article-title":"Genetic instability in osteoblastic tumors of the skeletal system","volume":"194","author":"Radig","year":"1998","journal-title":"Pathol Res Pract"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB349","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0165-4608(93)90116-4","article-title":"Unbalanced translocation resulting in the loss of the chromosome 17 short arm in an osteoblastoma","volume":"69","author":"Mascarello","year":"1993","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB350","first-page":"83","article-title":"Clonal chromosomal aberrations in a case of osteoblastoma","volume":"128","author":"van den Berg","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB351","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/BF02303500","article-title":"Microsatellite instability in sarcomas","volume":"5","author":"Martin","year":"1998","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB352","first-page":"82","article-title":"Aberrant gene expression in human osteosarcoma","volume":"128","author":"Wolf","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB353","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1038\/sj.onc.1204563","article-title":"Connexin43 suppresses proliferation of osteosarcoma U2OS cells through post-transcriptional regulation of p27","volume":"20","author":"Zhang","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB354","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/01.MP.0000043522.76788.0A","article-title":"Expression of platelet-derived growth factor-AA is associated with tumor progression in osteosarcoma","volume":"16","author":"Sulzbacher","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB355","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.onc.1201185","article-title":"The p19INK4D cyclin dependent kinase inhibitor gene is altered in osteosarcoma","volume":"15","author":"Miller","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB356","first-page":"10A","article-title":"Expression of transforming growth factor beta-1 and beta 3 (TGF-\u03b21 and TGB-\u03b23) in osteosarcomas is correlated with response to chemotherapy","volume":"13","author":"Henno","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB357","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0002-9440(10)64908-5","article-title":"The expression of ccn3(nov) gene in musculoskeletal tumors","volume":"160","author":"Manara","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB358","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/ijc.10277","article-title":"Expression of SSX genes in human osteosarcomas","volume":"98","author":"Naka","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB359","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1038\/sj.onc.1205339","article-title":"Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21","volume":"21","author":"Meza-Zepeda","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB360","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1053\/hupa.2000.8230","article-title":"Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study","volume":"31","author":"Oda","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB361","first-page":"697","article-title":"Mutational activation of K-ras gene is absent in human osteosarcoma","volume":"19","author":"Cui","year":"1991","journal-title":"Med Sci Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB362","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0165-4608(94)00115-R","article-title":"Mutational activation of ras genes is absent in pediatric osteosarcoma","volume":"79","author":"Antill\u00f3n-Kl\u00fcssmann","year":"1995","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB363","first-page":"18A","article-title":"CD44 and CD44V6 expression in osteosarcoma","volume":"14","author":"Reith","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB364","first-page":"2281","article-title":"Absence of the CD44 gene prevents sarcoma metastasis","volume":"62","author":"Weber","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB365","first-page":"9A","article-title":"GSTP1 hypermethylation after chemotherapy in osteosarcomas","volume":"14","author":"Bagu\u00e9","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB366","first-page":"311A","article-title":"Minichromosome maintenance protein 7 (MCM7) expression in osteosarcoma: an immunocytochemical study","volume":"15","author":"Hicks","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB367","first-page":"22A","article-title":"Immunohistochemical analysis of primary osteosarcoma of bone","volume":"15","author":"Rosenberg","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB368","first-page":"915","article-title":"The peripheral myelin protein 22 kDa (PMP22) gene is amplified in cell lines derived from glioma and osteogenic sarcoma: a new candidate for an oncogene?","volume":"10","author":"Liehr","year":"1997","journal-title":"Int J Oncol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB369","first-page":"1288","article-title":"Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma","volume":"8","author":"Haydon","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB370","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/jor.1100110310","article-title":"Distribution of integrins and their matrix ligands in osteogenic sarcomas","volume":"11","author":"Kawaguchi","year":"1993","journal-title":"J Orthop Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB371","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0002-9440(10)65471-5","article-title":"Anomalous cadherin expression in osteosarcoma: possible relationship to metastasis and morphogenesis","volume":"155","author":"Kashima","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB372","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0046-8177(99)90066-7","article-title":"Expression of E-cadherin in bone and soft tissue sarcomas: a possible role in epithelial differentiation","volume":"30","author":"Sato","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB373","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/modpathol.3880109","article-title":"Platelet-derived growth factor-AA and -\u03b1 receptor expression suggests an autocrine and\/or paracrine loop in osteosarcoma","volume":"13","author":"Sulzbacher","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB374","first-page":"363","article-title":"Plasminogen activators and their inhibitor in osteosarcomas and other bone tumors","volume":"140","author":"H\u00e4ckel","year":"1994","journal-title":"Zentralbl Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB375","first-page":"18A","article-title":"Fas (CD95) and Fas-ligand (CD95-L) expression in osteosarcoma (OS): analysis of 93 cases","volume":"14","author":"Reith","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB376","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/00000478-200204000-00011","article-title":"c-kit expression in pediatric solid tumors: a comparative immunohistochemical study","volume":"26","author":"Smithey","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB377","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ijc.10719","article-title":"Cytoplasmic and\/or nuclear accumulation of the \u03b2-catenin protein is a frequent event in human osteosarcoma","volume":"102","author":"Haydon","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB378","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0165-4608(94)90085-X","article-title":"The protooncogene CHOP\/GADD153, involved in growth arrest and DNA damage response, is amplified in a subset of human sarcomas","volume":"78","author":"Forus","year":"1994","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB379","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00019606-199309000-00003","article-title":"dbl oncogene expression in childhood tumors and tumor cell lines","volume":"2","author":"Navarro","year":"1993","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB380","first-page":"787","article-title":"Detection of chromosome 12q amplification in sarcomas by chromosome microdissection and interphase FISH","volume":"5","author":"Mitchell","year":"1994","journal-title":"Int J Oncol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB381","first-page":"90","article-title":"Multicolor spectral karyotyping of bone and cartilage tumors","volume":"123","author":"Sawyer","year":"2000","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB382","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0165-4608(02)00685-4","article-title":"Chromosomal alterations in osteosarcoma cell lines revealed by comparative genomic hybridization and multicolor karyotyping","volume":"140","author":"Ozaki","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB383","doi-asserted-by":"crossref","first-page":"8092","DOI":"10.1038\/sj.onc.1205009","article-title":"Genome instability in secondary solid tumors developing after radiotherapy of bilateral retinoblastoma","volume":"20","author":"Lef\u00e8vre","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB384","first-page":"15A","article-title":"Expression of prostaglandin H-synthase (COX2) in osteoid osteoma","volume":"14","author":"Lucio","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB385","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/(SICI)1096-911X(199803)30:3<165::AID-MPO7>3.0.CO;2-F","article-title":"Emergence of secondary acute leukemia in a patient treated for osteosarcoma: implications of germline TP53 mutations","volume":"30","author":"Panizo","year":"1998","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB386","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/cncr.10861","article-title":"Second malignant neoplasms in long-term survivors in osteosarcoma: Memorial Sloan-Kettering Cancer Center Experience","volume":"95","author":"Aung","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB387","article-title":"Correlations between galectin-3 expression and tumor invasiveness in human osteosarcoma cell lines","author":"Kim","year":"2001","journal-title":"Trans Orthop Res Soc"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB388","article-title":"Involvement of caspase-8 in the induction of osteosarcoma cell apoptosis by the novel triterpenoid CDDO","author":"Ito","year":"2001","journal-title":"Trans Orthop Res Soc"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB389","first-page":"783","article-title":"Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma","volume":"8","author":"Garc\u0131\u0301a-Castellano","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB390","article-title":"Induction of anti-tumor immunity on osteosarcoma by exogenous expression of B7\u20131A, an alternatively spliced form of B7\u20131 costimulatory adhesion molecule","author":"Nagamori","year":"2001","journal-title":"Trans Orthop Res Soc"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB391","article-title":"Preferential amplification of coding sequences (PACS): a novel approach to identifying genetic markers for osteogenic sarcoma and other skeletal tumors","author":"Sarkar","year":"2002","journal-title":"Trans Orthop Res Soc"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB392","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/cncr.10749","article-title":"Human osteosarcoma expresses specific ephrin profiles: implications for tumorigenicity and prognosis","volume":"95","author":"Varelias","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB393","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/jor.1100110311","article-title":"Expression of the multidrug resistance gene in osteosarcoma: a pilot study","volume":"11","author":"Wunder","year":"1993","journal-title":"J Orthop Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB394","first-page":"66","article-title":"Multiple drug resistance in osteosarcoma","volume":"15","author":"Rosier","year":"1995","journal-title":"Iowa Orthop J"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB395","first-page":"4439","article-title":"The poly(ADP-ribose) polymerase-1-regulated endonuclease DNAS1L3 is required for etoposide-induced internucleosomal DNA fragmentation and increases etoposide cytotoxicity in transfected osteosarcoma cells","volume":"62","author":"Boulares","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB396","first-page":"837","article-title":"Sequence alterations in the reduced folate carrier are observed in osteosarcoma samples","volume":"9","author":"Yang","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB397","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1002\/1097-0142(19930915)72:6<2033::AID-CNCR2820720640>3.0.CO;2-J","article-title":"DNA content measurement can be obtained using archival material for DNA flow cytometry: a comparison with cytogenetic analysis in 56 pediatric solid tumors","volume":"72","author":"Dressler","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB398","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0165-4608(96)00071-4","article-title":"Presence of double minutes and monosomy 17p in xenografted human osteosarcomas","volume":"90","author":"L\u00f3pez-Gin\u00e9s","year":"1996","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB399","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00043426-199901000-00013","article-title":"Multifocal osteosarcoma: an unusual presentation","volume":"21","author":"Gunawardena","year":"1999","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB400","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0165-4608(99)00105-3","article-title":"Radiation-associated sarcomas are characterized by complex karyotypes with frequent rearrangements of chromosome arm 3p","volume":"116","author":"Mertens","year":"2000","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB401","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/mp.55.6.389","article-title":"Evaluation of paediatric osteosarcomas by classic cytogenetic and CGH analyses","volume":"55","author":"Batanian","year":"2002","journal-title":"Mol Pathol"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB402","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/1097-0142(20011001)92:7<1992::AID-CNCR1719>3.0.CO;2-2","article-title":"Comparative genomic hybridization of postirradiation sarcomas","volume":"92","author":"Tarkkanen","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB403","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/0165-4608(92)90011-V","article-title":"Supernumerary ring chromosomes in five bone and soft tissue tumors of low or borderline malignancy","volume":"60","author":"\u00d6rndal","year":"1992","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0165-4608(03)00105-5_BIB404","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ijc.11070","article-title":"Determination of a minimal region of loss of heterozygosity on chromosome 18q21.33 in osteosarcoma","volume":"105","author":"Johnson-Pais","year":"2003","journal-title":"Int J Cancer"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460803001055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460803001055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T18:19:37Z","timestamp":1682533177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460803001055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":404,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["S0165460803001055"],"URL":"https:\/\/doi.org\/10.1016\/s0165-4608(03)00105-5","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2003,8]]}}}